African Journal of
Pharmacy and Pharmacology

  • Abbreviation: Afr. J. Pharm. Pharmacol.
  • Language: English
  • ISSN: 1996-0816
  • DOI: 10.5897/AJPP
  • Start Year: 2007
  • Published Articles: 2191

Full Length Research Paper

Prevalence and indication of gabapentin and pregabalin prescriptions among adults in King Abdulaziz Hospital in Makkah AL-Mukarramah, KSA

Salma Alotaibi
  • Salma Alotaibi
  • Pharm D Intern students, Faculty of pharmacy, University of Umm Al-Qura, Makkah, KSA.
  • Google Scholar
Arwa Alotaibi
  • Arwa Alotaibi
  • Pharm D Intern students, Faculty of pharmacy, University of Umm Al-Qura, Makkah, KSA.
  • Google Scholar
Ashwaq Almqati
  • Ashwaq Almqati
  • Pharm D Intern students, Faculty of pharmacy, University of Umm Al-Qura, Makkah, KSA.
  • Google Scholar
Khloud Alotaibi
  • Khloud Alotaibi
  • Pharm D Intern students, Faculty of pharmacy, University of Umm Al-Qura, Makkah, KSA.
  • Google Scholar
Atyaf Bogar
  • Atyaf Bogar
  • Pharm D Intern students, Faculty of pharmacy, University of Umm Al-Qura, Makkah, KSA.
  • Google Scholar
Yosra Alhindi
  • Yosra Alhindi
  • Assisstant Professor in clinical pharmacy, Faculty of pharmacy, University of Umm Al-Qura, Makkah, KSA.
  • Google Scholar


  •  Received: 26 August 2019
  •  Accepted: 23 September 2019
  •  Published: 31 October 2019

References

Baidya DK, Agarwal A, Khanna P, Arora MK (2011). Pregabalin in acute and chronic pain. Journal of anaesthesiology, clinical pharmacology 27(3):307.
Crossref

 

Boos J (2003). Off label use-label off use. Annals of Oncology 14:1-5.
Crossref

 

Canadian Agency for Drugs and Technologies in Health (CADTH) (2012). Abuse and misuse potential of pregabalin: A review of the clinical evidence; Context and policy issues, 

 

Cheng JK, Chiou LC (2006). Mechanisms of the antinociceptive action of gabapentin. Journal of Pharmacological Sciences, 0602100009-0602100009.

 

Filipetto FA, Zipp CP, Coren JS (2010). Potential for pregabalin abuse or diversion after past drug-seeking behavior. The Journal of the American Osteopathic Association 110(10):605-607.

 

Fleet JL, Dixon SN, Kuwornu PJ, Dev VK, Montero-Odasso M, Burneo J, Garg AX (2018). Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study. PloS One 13(3):e0193134.
Crossref

 

Gazarian M, Kelly M, McPhee JR, Graudins LV, Ward RL, Campbell TJ (2006). Off‐label use of medicines: consensus recommendations for evaluating appropriateness. Medical Journal of Australia 185(10):544-548.
Crossref

 

Grice GR, Mertens MK (2008). Gabapentin as a potential option for treatment of sciatica. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28(3):397-402.
Crossref

 

Grosshans M, Lemenager T, Vollmert C, Kaemmerer N, Schreiner R, Mutschler J, Hermann D (2013). Pregabalin abuse among opiate addicted patients. European Journal of Clinical Pharmacology 69(12):2021-2025.
Crossref

 

Han C, Li X, Jiang H, Ma J, Ma X (2016). The use of gabapentin in the management of postoperative pain after total hip arthroplasty: a meta-analysis of randomised controlled trials. Journal of Orthopaedic Surgery and Research 11(1):79.
Crossref

 

Haw C, Stubbs J (2005). A survey of the off-label use of mood stabilizers in a large psychiatric hospital. Journal of Psychopharmacology 19(4):402-407.
Crossref

 

Moore A, Wiffen P, Kalso E (2014). Antiepileptic drugs for neuropathic pain and fibromyalgia. Jama 312(2):182-183.
Crossref

 

Morrison EE, Sandilands EA, Webb DJ (2017). Gabapentin and pregabalin: do the benefits outweigh the harms?. Journal of the Royal College of Physicians of Edinburgh 47(4):310-313.
Crossref

 

Peckham AM, Fairman KA, Sclar DA (2017). Prevalence of Gabapentin Abuse: Comparison with Agents with Known Abuse Potential in a Commercially Insured US Population. Jounal of Clinical Drug Investig 37:763.
Crossref

 

Schwan S, Sundström A, Stjernberg E, Hallberg E, Hallberg P (2010). A signal for an abuse liability for pregabalin-results from the Swedish spontaneous adverse drug reaction reporting system. European Journal of Clinical Pharmacology 66(9):947-953.
Crossref

 

Wiffen PJ, Derry S, Bell RF, Rice ASC, Tölle TR, Phillips T, Moore RA (2017). Gabapentin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews.
Crossref